Circulating microRNA profile as a potential biomarker for obstructive sleep apnea diagnosis

Evaluation of microRNAs (miRNAs) could allow characterization of the obstructive sleep apnea (OSA) and help diagnose it more accurately. We aimed to examine circulating miRNA profiles to establish the differences between non-OSA and OSA patients. Additionally, we aimed to analyse the effect of conti...

Descripción completa

Detalles Bibliográficos
Autores: Santamaria-Martos, Fernando, Benítez, Iván, Ortega Delgado, Francisco José, Zapater, Andrea, Giron, Cristina, Pinilla, Lucía, Pacual, Lydia, Cortijo, Anunciación, Dalmases, Mireia, Fernández Real, José Manuel, Barbé Illa, Ferran, Sánchez de la Torre, Manuel
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2019
País:España
Institución:Universitat de Lleida (UdL)
Repositorio:Repositori Obert UdL
OAI Identifier:oai:repositori.udl.cat:10459.1/68181
Acceso en línea:https://doi.org/10.1038/s41598-019-49940-1
http://hdl.handle.net/10459.1/68181
Access Level:acceso abierto
Palabra clave:MicroARN
Marcadors bioquímics
Síndromes d'apnea del son
Descripción
Sumario:Evaluation of microRNAs (miRNAs) could allow characterization of the obstructive sleep apnea (OSA) and help diagnose it more accurately. We aimed to examine circulating miRNA profiles to establish the differences between non-OSA and OSA patients. Additionally, we aimed to analyse the effect of continuous positive airway pressure (CPAP) treatment on the miRNA profile. This observational, longitudinal study included 230 subjects referred to the Sleep Unit due to suspected OSA. Expression profiling of 188 miRNAs in plasma was performed in 27 subjects by TaqMan-Low-Density-Array. OSA-related miRNAs were selected for validation by RT-qPCR in 203 patients. Prediction models were built to discriminate between non-OSA and OSA: 1) NoSAS-score, 2) differentially expressed miRNAs, and 3) combination of NoSAS-score plus miRNAs. The differentially expressed miRNAs were measured after 6 months of follow-up. From the 14 miRNAs selected for validation, 6 were confirmed to be differentially expressed. The areas under the curve were 0.73 for the NoSAS-score, 0.81 for the miRNAs and 0.86 for the combination. After 6 months of CPAP treatment, miRNA levels in the OSA group seem to approximate to non-OSA levels. A cluster of miRNAs was identified to differentiate between non-OSA and OSA patients. CPAP treatment was associated with changes in the circulating miRNA profile.

Similares en LA Referencia